Small cell B-cell lymphoma, in remission is a type of non-Hodgkin lymphoma characterized by the proliferation of small B-lymphocytes. This condition is clinically significant as it indicates a stage where the disease is no longer active, allowing for appropriate management and monitoring. The ICD-10 Code C83.0A facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track treatment outcomes and resource utilization.
ICD-10 Code C83.0A represents Small cell B-cell lymphoma, in remission, a condition where the malignant B-cells are no longer detectable or causing symptoms. This code is used in clinical documentation and billing when a patient has achieved remission following treatment, allowing for appropriate follow-up care and monitoring of potential recurrence.
Small cell B-cell lymphoma, in remission, is a hematological malignancy that arises from small B-lymphocytes. The condition can progress from an aggressive state to remission through effective treatment, necessitating ongoing medical supervision to monitor for relapse. Early detection and management are crucial for improving patient outcomes.
ICD-10 Code C83.0A is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's health status and treatment response.
In SOAP notes, ICD-10 Code C83.0A connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of remission. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of Small cell B-cell lymphoma, in remission focuses on monitoring and supportive care to prevent relapse. Treatment strategies may vary based on individual patient needs.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.0A is essential for accurate billing in hospital, ER, or infectious disease care settings, reflecting the patient's remission status.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with differential. |
| 36415 | Collection of venous blood by venipuncture. |
Common Questions About Using ICD-10 Code C83.0A for Small cell B-cell lymphoma, in remission
What does it mean for Small cell B-cell lymphoma to be in remission?
Remission indicates that the signs and symptoms of Small cell B-cell lymphoma are no longer present, and the disease is not detectable through clinical evaluation or imaging.
How often should patients with Small cell B-cell lymphoma in remission be monitored?
Patients should typically be monitored every 3 to 6 months, depending on individual risk factors and physician recommendations, to detect any signs of recurrence early.
Can Small cell B-cell lymphoma come back after remission?
Yes, Small cell B-cell lymphoma can recur after remission, which is why ongoing monitoring and follow-up care are essential for early detection and management.
What are the common treatments for Small cell B-cell lymphoma?
Common treatments include chemotherapy, radiation therapy, and targeted therapies, depending on the stage and characteristics of the lymphoma.
Clinical Notes
SOAP notes
DAP notes
AI medical notes